PRE 14A

PRE 14A

Company: REVIVA PHARMACEUTICALS HOLDINGS, INC.
Filed: January 16, 2020
Period of Report: January 16, 2020
Accession Number: 0001104659-20-004788

View Document ↗ View on SEC.gov ↗